Envestnet Asset Management Inc Biotechnology

Envestnet Asset Management Inc

$299 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
AGIO Agios Pharmaceuticals, Inc.	$2.21B	$660,000 0.0% of portfolio	22,553	Q1 2025 Reduced 9.08%
MRUS Merus N.V.	$2.82B	$588,000 0.0% of portfolio	13,984	Q1 2025 New
BEAM Beam Therapeutics Inc.	$1.44B	$579,000 0.0% of portfolio	29,682	Q1 2025 Reduced 2.58%
MLTX Moon Lake Immunotherapeutics	$1.81B	$555,000 0.0% of portfolio	14,225	Q1 2025 Added 58.57%
AKRO Akero Therapeutics, Inc.	$2.52B	$539,000 0.0% of portfolio	13,334	Q1 2025 Added 31.19%
NTLA Intellia Therapeutics, Inc.	$899M	$520,000 0.0% of portfolio	73,150	Q1 2025 Added 9.75%
MRNA Moderna, Inc.	$12.6B	$513,000 0.0% of portfolio	18,102	Q1 2025 Reduced 40.29%
NUVL Nuvalent, Inc.	$3.68B	$462,000 0.0% of portfolio	6,520	Q1 2025 Reduced 2.29%
TARS Tarsus Pharmaceuticals, Inc.	$1.1B	$459,000 0.0% of portfolio	8,938	Q1 2025 Reduced 26.33%
AVXL Anavex Life Sciences Corp.	$862M	$454,000 0.0% of portfolio	53,002	Q1 2025 Reduced 10.27%
IONS Ionis Pharmaceuticals Inc	$5.99B	$453,000 0.0% of portfolio	15,039	Q1 2025 Reduced 71.46%
BBIO Bridge Bio Pharma, Inc.	$6.93B	$448,000 0.0% of portfolio	12,987	Q1 2025 Added 0.47%
DNLI Denali Therapeutics Inc.	$1.95B	$427,000 0.0% of portfolio	31,430	Q1 2025 Reduced 16.46%
EWTX Edgewise Therapeutics, Inc.	$867M	$338,000 0.0% of portfolio	15,399	Q1 2025 Added 4.91%
ROIV Roivant Sciences Ltd.	$8.21B	$331,000 0.0% of portfolio	32,874	Q1 2025 Added 22.11%
VERU Veru Inc.	$48.9M	$326,000 0.0% of portfolio	666,294	Q1 2025 Added 63.81%
WVE Wave Life Sciences Ltd.	$695M	$292,000 0.0% of portfolio	36,192	Q1 2025 Added 11.94%
SRRK Scholar Rock Holding Corp	$2.21B	$273,000 0.0% of portfolio	8,512	Q1 2025 Reduced 6.18%
RVMD Revolution Medicines, Inc.	$3.42B	$248,000 0.0% of portfolio	7,026	Q1 2025 Reduced 38.5%
RCKT Rocket Pharmaceuticals, Inc.	$253M	$228,000 0.0% of portfolio	34,286	Q1 2025 Added 5.75%
ETON Eton Pharmaceuticals, Inc.	$395M	$224,000 0.0% of portfolio	17,316	Q1 2025 Reduced 2.39%
INVA Innoviva, Inc.	$1.39B	$224,000 0.0% of portfolio	12,409	Q1 2025 Reduced 16.45%
ABSI Absci Corp	$267M	$201,000 0.0% of portfolio	80,170	Q1 2025 Added 0.78%
OLMA Olema Pharmaceuticals, Inc.	$182M	$175,000 0.0% of portfolio	46,699	Q1 2025 Reduced 6.72%
REPL Replimune Group, Inc.	$616M	$150,000 0.0% of portfolio	15,405	Q1 2025 New
CAPR Capricor Therapeutics, Inc.	$175M	$114,000 0.0% of portfolio	12,048	Q1 2025 New
ALT Altimmune, Inc.	$199M	$111,000 0.0% of portfolio	22,237	Q1 2025 New
BCYC Bicycle Therapeutics PLC	$239M	$105,000 0.0% of portfolio	12,420	Q1 2025 New
BCRX Biocryst Pharmaceuticals Inc	$1.62B	$77,000 0.0% of portfolio	10,282	Q1 2025 New
VNDA Vanda Pharmaceuticals Inc.	$275M	$75,000 0.0% of portfolio	16,364	Q1 2025 New
IOVA Iovance Biotherapeutics, Inc.	$369M	$74,000 0.0% of portfolio	22,383	Q1 2025 Reduced 19.86%
CDXC Chroma Dex Corp.	$420M	$69,000 0.0% of portfolio	10,000	Q3 2023 Reduced 37.52%
PGEN Precigen, Inc.	$379M	$65,000 0.0% of portfolio	43,941	Q1 2025 Added 66.8%
IMUX Immunic, Inc.	$30.3M	$60,000 0.0% of portfolio	55,114	Q1 2025 New
ABCL Ab Cellera Biologics Inc.	$1.11B	$48,000 0.0% of portfolio	21,960	Q1 2025 Added 19.17%
HRTX Heron Therapeutics, Inc.	$238M	$41,000 0.0% of portfolio	18,930	Q1 2025 Added 6.66%
CRBU Caribou Biosciences, Inc.	$111M	$39,000 0.0% of portfolio	43,845	Q1 2025 Reduced 5.3%
CABA Cabaletta Bio, Inc.	$43.8M	$35,000 0.0% of portfolio	25,540	Q1 2025 Reduced 34.35%
ALLO Allogene Therapeutics, Inc.	$178M	$28,000 0.0% of portfolio	19,295	Q1 2025 Reduced 8.51%
HUMA Humacyte, Inc.	$249M	$19,000 0.0% of portfolio	11,605	Q1 2025 New
OCGN Ocugen, Inc.	$217M	$7,000 0.0% of portfolio	10,000	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.